• 210. Exits: $10.8B Exit to Merck with Prometheus Biosciences CEO Mark McKenna

  • Sep 25 2024
  • Length: 26 mins
  • Podcast
  • 5.0 out of 5 stars (1 rating)

210. Exits: $10.8B Exit to Merck with Prometheus Biosciences CEO Mark McKenna

  • Summary

  • 00:00 Introduction and Welcome

    00:32 Guest Introduction: Mark McKenna

    00:42 The Prometheus Acquisition by Merck

    01:01 Mark's Career Journey and Decision to Join Prometheus

    04:55 Challenges and Strategies in the First Year

    06:48 Key Inflection Points and Fundraising

    08:58 Building a Competitive and Sustainable Company

    13:32 Navigating Market Challenges and Competition

    19:33 Reflections and Leadership Insights

    21:32 Future of Biotech and Industry Concerns

    24:42 Conclusion and Farewell


    For limited time only - Get the Medical Sales Network Effects Program for 60% off https://salesnetworkeffectsprogram.mykajabi.com/offers/FV2MG8sK?coupon_code=PODCAST2024

    Follow The State of MedTech on:

    • ⁠⁠⁠⁠LinkedIn⁠⁠⁠⁠
    • ⁠⁠⁠⁠Instagram⁠⁠⁠⁠
    • TikTok
    • ⁠⁠⁠⁠Twitter⁠⁠⁠⁠
    • ⁠⁠⁠⁠Facebook⁠⁠⁠⁠

    Follow Omar M. Khateeb on

    • ⁠⁠⁠⁠LinkedIn⁠⁠⁠⁠
    • ⁠⁠⁠⁠Instagram⁠⁠⁠⁠
    • TikTok
    • ⁠⁠⁠⁠Twitter⁠⁠⁠⁠
    • ⁠⁠⁠⁠Facebook⁠⁠
    Show more Show less
activate_Holiday_promo_in_buybox_DT_T2

What listeners say about 210. Exits: $10.8B Exit to Merck with Prometheus Biosciences CEO Mark McKenna

Average customer ratings
Overall
  • 5 out of 5 stars
  • 5 Stars
    1
  • 4 Stars
    0
  • 3 Stars
    0
  • 2 Stars
    0
  • 1 Stars
    0
Performance
  • 5 out of 5 stars
  • 5 Stars
    1
  • 4 Stars
    0
  • 3 Stars
    0
  • 2 Stars
    0
  • 1 Stars
    0
Story
  • 5 out of 5 stars
  • 5 Stars
    1
  • 4 Stars
    0
  • 3 Stars
    0
  • 2 Stars
    0
  • 1 Stars
    0

Reviews - Please select the tabs below to change the source of reviews.

Sort by:
Filter by:
  • Overall
    5 out of 5 stars
  • Performance
    5 out of 5 stars
  • Story
    5 out of 5 stars

Solid

What a strong 💪 hold on the market such a great lesson. Build the business to survive not to buy

Something went wrong. Please try again in a few minutes.

You voted on this review!

You reported this review!